ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,555Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 118

$585K Total Retail Price of All Prescriptions

Rank: 10 out of 118

723 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Vermont
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 723 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

5% of this provider’s 723 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LEVOTHYROXINE SODIUM 620 535 83 1 3
SIMVASTATIN 586 485 119 2 1
LISINOPRIL 563 508 103 3 2
HYDROCHLOROTHIAZIDE 520 479 97 4 7
OMEPRAZOLE 450 376 97 5 4
FUROSEMIDE 408 350 74 6 5
METOPROLOL SUCCINATE 387 363 57 7 11
METOPROLOL TARTRATE 354 291 62 8 10
WARFARIN SODIUM 350 295 36 9 9
ATORVASTATIN CALCIUM 320 282 60 10 8
AMLODIPINE BESYLATE 279 255 60 11 6
GABAPENTIN 242 168 39 12 15
LOSARTAN POTASSIUM 240 235* 44 13 16
PAROXETINE HCL 213 151 30 14 69
ATENOLOL 211 186 46 15 12
POTASSIUM CHLORIDE 181 148 33 16 23
SERTRALINE HCL 172 144 29 17 19
METFORMIN HCL 157 134 38 18 14
TRAZODONE HCL 156 129 35 19 22
ENALAPRIL MALEATE 152 152 26 20 54
CLOPIDOGREL 139 134* 26 21 26
QUETIAPINE FUMARATE 134 114 26 A 22 37
LOVASTATIN 131 126* 27 23 40
RANITIDINE HCL 127 122* 21 24 39
TAMSULOSIN HCL 127 122* 22 24 31
OXYCONTIN 119 53 16 S2 26 83
OXYCODONE HCL 115 45 31 S2 27 29
OXYCODONE-ACETAMINOPHEN 108 34 14 S2 28 41
CLONAZEPAM 107 77 18 B 29 24
LORAZEPAM 104 79 30 B 30 13
ZOLPIDEM TARTRATE 103 69 31 31 21
CITALOPRAM HBR 103 70 19 31 18
HYDROCODONE-ACETAMINOPHEN 102 78 26 S3 33 17
PANTOPRAZOLE SODIUM 100 82 17 34 27
DONEPEZIL HCL 95 95 16 35 32
FINASTERIDE 83 <11 <11 36 72
FLUOXETINE HCL 82 77* 13 37 44
AMITRIPTYLINE HCL 78 55 16 R 38 79
SPIRIVA 76 71* 11 39 34
DILTIAZEM 24HR ER 73 68* 16 40 84
MORPHINE SULFATE ER 70 <11 <11 S2 41 46
PROPRANOLOL HCL 70 <11 <11 41 101
METFORMIN HCL ER 69 64* 13 43 78
SPIRONOLACTONE 67 52 17 44 71
KLOR-CON M20 66 37 13 45 85
LANTUS 66 54 12 45 49
GLIPIZIDE XL 65 65 11 47 89
DIOVAN 65 <11 <11 47 42
GLIPIZIDE 65 65 13 47 82
PROAIR HFA 64 42 27 50 30
ADVAIR DISKUS 62 44 16 51 35
DIAZEPAM 59 44 14 B 52 67
FAMOTIDINE* 58 <11 <11 53 66
MONTELUKAST SODIUM 57 <11 <11 54 75
PREDNISONE 55 28 19 55 28
TRIAMTERENE-HCTZ 55 <11 <11 55 91
CYCLOBENZAPRINE HCL 53 <11 13 R 57 93
OXYCODONE HCL-ACETAMINOPHEN 53 <11 <11 S2 57 126
FENTANYL 52 41 14 S2 59 48
TRAMADOL HCL 52 37 16 59 20
ALLOPURINOL 50 45* 12 61 36
PIOGLITAZONE HCL 50 <11 <11 R 61 86
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.